Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00525278Phase 3Completed
A Phase 3 trial of levocetirizine in seasonal allergic rhinitis (SAR), sponsored by UCB. Started Aug 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00525278.